publication venue for
- Fluorine‐19 Magnetic Resonance Imaging of Activated Platelets. 9:e016971. 2020
- Cluster‐Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change. 9:1-13 + i-v. 2020
- Anti‐TIM‐1 Monoclonal Antibody (RMT1‐10) Attenuates Atherosclerosis By Expanding IgM‐producing B1a Cells. 7. 2018
- Cardiomyocyte functional etiology in heart failure with preserved ejection fraction is distinctive-a new preclinical model. 7. 2018
- Cognitive Impairment and Risk of All-Cause and Cardiovascular Disease Mortality Over 20-Year Follow-Up: Results from the BLSA. 7:1-11. 2018
- Experimental and human evidence for Lipocalin‐2 (Neutrophil Gelatinase‐Associated Lipocalin [NGAL]) in the development of cardiac hypertrophy and heart failure. 6. 2017
- Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single‐Chain Antibody Specific for Activated GPIIb/IIIa. 6. 2017
- Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease. 5:e002891-e002891. 2016
- Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. 5:1-13. 2016
- Particulate Matter and Hospital Admissions for Stroke in Beijing, China: Modification Effects by Ambient Temperature. 5. 2016
- Toll‐like receptor (TLR)4 and MyD88 are essential for atheroprotection by peritoneal B1a B cells. 5. 2016
- Acute Intravenous Injection of Serelaxin (Recombinant Human Relaxin-2) Causes Rapid and Sustained Bradykinin-Mediated Vasorelaxation. 3:1-15. 2014
- Correction to: Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. [J Am Heart Assoc. (2016) 5, e002891.] Doi:10.1161/JAHA.115.002891. 2016